Olivier Gouédard
Operationeel Directeur bij Cytovia Therapeutics, Inc.
Profiel
Olivier Gouédard is currently the Chief Operating Officer at Cytovia Therapeutics, Inc. He holds an MBA from New York University, a doctorate from the University of Rennes, and an undergraduate degree from Université Paris-Saclay.
Actieve functies van Olivier Gouédard
| Bedrijven | Functie | Begin |
|---|---|---|
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Operationeel Directeur | 22-06-2021 |
Opleiding van Olivier Gouédard
| New York University | Masters Business Admin |
| Université Paris-Saclay | Undergraduate Degree |
| University of Rennes | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
